Filtered By:
Vaccination: Influenza Vaccine
Countries: Germany Health

This page shows you your search results in order of date.

Order by Relevance | Date

Total 5 results found since Jan 2013.

Myocarditis update from Sweden
BY ANISH KOKA The COVID19/vaccine myocarditis debate continues in large part because our public health institutions are grossly mischaracterizing the risks and benefits of vaccines to young people. A snapshot of what the establishment says as it relates to the particular area of concern: college vaccine mandates: Dr. Arthur Reingold, an epidemiology professor at UC-Berkeley, notes that UC also requires immunizations for measles and chickenpox, and people still are dying from COVID at rates that exceed those for influenza. As of Feb. 1, there were more than 400 COVID deaths a day across the U.S. “The arg...
Source: The Health Care Blog - February 27, 2023 Category: Consumer Health News Authors: Ryan Bose-Roy Tags: Medical Practice Anish Koka covid19 myocarditis Sweden Source Type: blogs

Brand-Specific Enhanced Safety Surveillance Study of GSK ’s Quadrivalent Seasonal Influenza Vaccine, Conducted During the COVID-19 Pandemic, in Belgium, Germany and Spain, for the 2020/21 Season
ConclusionThis ESS study assessed AEs in near real time. The COVID-19 pandemic did not alter the safety profile of GSK ’s IIV4. No safety signals were detected during the study, which confirms the excellent safety profile of GSK’s IIV4.
Source: Infectious Diseases and Therapy - December 27, 2021 Category: Infectious Diseases Source Type: research

Brand-Specific Enhanced Safety Surveillance of GSK ’s Quadrivalent Seasonal Influenza Vaccine in Belgium, Germany and Spain for the 2018/2019 Season
ConclusionIn compliance with EMA guidance, this study design allowed for near real-time assessment of AEs. No safety signals were detected at any point during the study period. The study supports and confirms the acceptable safety profile of GSK ’s IIV4.ClinicalTrials.gov identifierNCT03688620.
Source: Drug Safety - December 27, 2019 Category: Drugs & Pharmacology Source Type: research

Funtabulously Frivolous Friday Five 233
LITFL • Life in the Fast Lane Medical Blog LITFL • Life in the Fast Lane Medical Blog - Emergency medicine and critical care medical education blog Just when you thought your brain could unwind on a Friday, you realise that it would rather be challenged with some good old fashioned medical trivia FFFF…introducing Funtabulously Frivolous Friday Five 233. Readers can subscribe to FFFF RSS or subscribe to the FFFF weekly EMAIL Question 1: Who popularised museli? + Reveal the Funtabulous Answer expand(document.getElementById('ddet201504324'));expand(document.getElementById('ddetlink201504324')) Dr Maximilian Birc...
Source: Life in the Fast Lane - April 6, 2018 Category: Emergency Medicine Authors: Neil Long Tags: Frivolous Friday Five Bircher Bircher Museli Clare Stanton Ekbom syndrome II Ernest W Goodpasture Essex Lopresti Goodpastures disease hugo flecker irukandji irukandji syndrome jack barnes John Range Maximilian Bircher-Benner Pa Source Type: blogs